{
    "clinical_study": {
        "@rank": "141345", 
        "acronym": "SEVOBURN", 
        "arm_group": [
            {
                "arm_group_label": "burn ICU patients", 
                "arm_group_type": "Experimental", 
                "description": "Determination of plasmatic concentrations of sevoflurane at different times of a short term sedation of sevoflurane in burn versus non burn ICU patients"
            }, 
            {
                "arm_group_label": "non burn ICU patients", 
                "arm_group_type": "Other", 
                "description": "Determination of plasmatic concentrations of sevoflurane at different times of a short term sedation of sevoflurane in burn versus non burn ICU patients"
            }
        ], 
        "brief_summary": {
            "textblock": "Comparing a pharmacokinetic model of a short sevoflurane sedation in burn ICU patients with\n      control ICU patients."
        }, 
        "brief_title": "A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "ICU Patients With Indication of Sedation", 
        "detailed_description": {
            "textblock": "Prospective clinical study in ICU with sedated ventilated patients with sevoflurane with the\n      AnaConda\u00ae system, establishing pharmacokinetic model of sevoflurane and its metabolites\n      (hydroxyfluroisopropanol, fluoride) comparing burn and non burn ICU patients"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients ventilated requiring invasive procedure in ICU\n\n               -  Stable respiratory and hemodynamic conditions\n\n               -  Consent of patients or family\n\n               -  Arterial line\n\n               -  Burn patients : burn area between 20 and 50% (3rd degree) OR non burn patients\n\n        Exclusion Criteria:\n\n          -  BMI <30\n\n               -  Sevoflurane anaphylaxia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02048683", 
            "org_study_id": "CHU-0174", 
            "secondary_id": "2013-000960-26"
        }, 
        "intervention": {
            "arm_group_label": [
                "burn ICU patients", 
                "non burn ICU patients"
            ], 
            "intervention_name": "Short term sedation with sevoflurane in ICU", 
            "intervention_type": "Drug", 
            "other_name": "Short term sedation with sevoflurane in ICU"
        }, 
        "intervention_browse": {
            "mesh_term": "Sevoflurane"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pharmacokinetics", 
            "Sevoflurane", 
            "Burn", 
            "Sedation"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "location": {
            "contact": {
                "email": "placarin@chu-clermontferrand.fr", 
                "last_name": "Patrick LACARIN", 
                "phone": "04 73 75 11 95"
            }, 
            "facility": {
                "address": {
                    "city": "Clermont-Ferrand", 
                    "country": "France", 
                    "zip": "63003"
                }, 
                "name": "CHU Clermont-Ferrand"
            }, 
            "investigator": [
                {
                    "last_name": "Matthieu LEGRAND", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alexandre MEBAZAA", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Daniel BOURDEAUX", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Etienne BAZIN", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Michel CONSTANTIN", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients", 
        "overall_contact": {
            "email": "placarin@chu-clermontferrand.fr", 
            "last_name": "Patrick LACARIN", 
            "phone": "04 73 75 11 95"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Clermont-Ferrand", 
            "last_name": "S\u00e9bastien PERBET", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Determination of plasmatic concentrations of sevoflurane", 
            "safety_issue": "No", 
            "time_frame": "at 5min, 15 min, 60 min and just before the end of sedation."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02048683"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Determination of plasmatic concentrations of HFIP and fluoride", 
            "safety_issue": "No", 
            "time_frame": "at 5min, 15 min, 60 min and just before the end of sedation. And 5min, 10 min, 30 min, 60 min and 120 min after the end of sedation"
        }, 
        "source": "University Hospital, Clermont-Ferrand", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Clermont-Ferrand", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}